Literature DB >> 16077032

Substance P, neurokinins A and B, and synthetic tachykinin peptides protect mesencephalic dopaminergic neurons in culture via an activity-dependent mechanism.

Bénédicte Salthun-Lassalle1, Sabine Traver, Etienne C Hirsch, Patrick P Michel.   

Abstract

We evaluated the neuroprotective potential of tachykinin peptides using a model system in which mesencephalic dopaminergic (DA) neurons die spontaneously and selectively as they mature. The three native tachykinins, substance P (SP), neurokinin (NK) A, and NKB afforded substantial protection against DA cell demise. The selective NK1 receptor antagonist [D-Pro9,[spiro-gamma-lactam] Leu10,Trp11]substance P (GR71251) was sufficient in itself to suppress the effect of SP, whereas a cotreatment with GR71251 and the NK3 receptor antagonist (R)-N-[alpha-(methoxycarbonyl)benzyl]-2-phenylquinoline-4-carboxamide (SB218795) was required to prevent the effects of both NKA and NKB. Consistent with these results, D-Ala-[L-Pro9,Me-Leu8]substance P(7-11) (GR73632), a selective agonist of NK1 receptors and [pro7]-NKB, a selective agonist of NK3 receptors, conferred protection to DA neurons, whereas (Lys3, Gly8-R-gamma-lactam-Leu9)neurokinin A(3-10) (GR64349), which activates specifically NK2 receptors, did not. DA neurons rescued by tachykinins accumulated [3H]DA efficiently, which suggests that they were also totally functional. Neuroprotection by tachykinins was highly selective for DA neurons, rapidly reversed upon treatment withdrawal, and reproduced by but independent of glial cell line-derived neurotrophic factor. Survival promotion by tachykinins was abolished by blocking voltage-gated Na+ channels with tetrodotoxin or N-type voltage-gated Ca2+ channels with omega-conotoxin-MVIIA, which indicates that an increase in neuronal excitability was crucially involved in this effect. Together, these data further support the notion that the survival of mesencephalic DA neurons during development depends largely on excitatory inputs, which may be provided in part by tachykinins.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16077032     DOI: 10.1124/mol.105.015453

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  6 in total

1.  Modulation of lymphatic muscle contractility by the neuropeptide substance P.

Authors:  Michael J Davis; Megan M Lane; Ann M Davis; David Durtschi; David C Zawieja; Mariappan Muthuchamy; Anatoliy A Gashev
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-06-06       Impact factor: 4.733

2.  Peptide hormone ghrelin enhances neuronal excitability by inhibition of Kv7/KCNQ channels.

Authors:  Limin Shi; Xiling Bian; Zhiqiang Qu; Zegang Ma; Yu Zhou; KeWei Wang; Hong Jiang; Junxia Xie
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

Review 3.  The mammalian tachykinin ligand-receptor system: an emerging target for central neurological disorders.

Authors:  Nick Pantaleo; Wayne Chadwick; Sung-Soo Park; Liyun Wang; Yu Zhou; Bronwen Martin; Stuart Maudsley
Journal:  CNS Neurol Disord Drug Targets       Date:  2010-11       Impact factor: 4.388

Review 4.  Dopamine and aging: intersecting facets.

Authors:  C David Rollo
Journal:  Neurochem Res       Date:  2008-10-08       Impact factor: 3.996

5.  Enhancing Post-Stroke Rehabilitation and Preventing Exo-Focal Dopaminergic Degeneration in Rats-A Role for Substance P.

Authors:  Sibylle Frase; Franziska Löffler; Jonas A Hosp
Journal:  Int J Mol Sci       Date:  2022-03-31       Impact factor: 5.923

6.  Systemic administration of substance P recovers beta amyloid-induced cognitive deficits in rat: involvement of Kv potassium channels.

Authors:  Patrizia Campolongo; Patrizia Ratano; Maria Teresa Ciotti; Fulvio Florenzano; Stefania Lucia Nori; Roberta Marolda; Maura Palmery; Anna Maria Rinaldi; Cristina Zona; Roberta Possenti; Pietro Calissano; Cinzia Severini
Journal:  PLoS One       Date:  2013-11-12       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.